Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 2    entities : Infinity pharmaceuticals, inc.    save search

Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium
Published: 2021-12-10 (Crawled : 14:30) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.29% H: 0.0% C: 0.0%

phase 2 symposium trial cancer breast cancer
Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -25.68% H: 4.24% C: -7.88%

phase 2 cancer breast cancer trial
Infinity Pharmaceuticals Hosting Webinar on MARIO-3 and MARIO-275 Phase 2 Trials
Published: 2021-07-20 (Crawled : 13:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.49% H: 0.37% C: -3.3%

phase 2 trial
Infinity Pharmaceuticals Announces Conference Call for the ASCO Genitourinary Cancers Symposium to Discuss Clinical Data from MARIO-275 Phase 2 Study
Published: 2021-02-10 (Crawled : 00:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 3.34% H: 3.23% C: -8.78%

phase 2 cancer symposium
Infinity Pharmaceuticals Announces MARIO-275 Phase 2 Data in Patients with Advanced Urothelial Cancer to be Presented at ASCO Genitourinary Cancers Symposium
Published: 2021-01-11 (Crawled : 16:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.63% H: 13.65% C: 6.43%

cancer phase 2 symposium
Infinity Pharmaceuticals Presents Front-Line Triple Negative Breast Cancer Data from Ongoing Phase 2 MARIO-3 Trial at the 2020 San Antonio Breast Cancer Symposium
Published: 2020-12-09 (Crawled : 16:00) - biospace.com/
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 10.47% H: 2.29% C: -26.8%

breast cancer cancer trial phase 2 ongoing symposium
Gainers vs Losers
49% 51%

Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M twitter stocktwits trandingview |
Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M twitter stocktwits trandingview |

HUBC | $1.94 49.23% 32.99% 73M twitter stocktwits trandingview |
n/a

SPCB | $0.4044 46.52% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M twitter stocktwits trandingview |
Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M twitter stocktwits trandingview |

AMBI | $3.72 -26.77% 21.77% 9.8K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.